<DOC>
	<DOC>NCT01012531</DOC>
	<brief_summary>The objective of this study is to assess the efficacy and safety of cluster immunotherapy with highly polymerized allergen extracts.</brief_summary>
	<brief_title>Efficacy and Safety of Specific Immunotherapy With CLUSTOID Grass Pollen</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>Positive history of allergic rhinitis/rhinoconjunctivitis due to grass and/or rye pollen Positive screening skin prick test (wheal diameter &gt; 3 mm) Compliance and ability of the patient to complete a Diary Card for selfevaluating of the symptoms and antisymptomatic medication Signed and dated patient´s Informed Consent, Previous immunotherapy with grass and/or rye pollen extracts within the last 3 years, Simultaneous participation in other clinical trials, Other reasons contraindicating an inclusion into the trial according to the investigator´s estimation (e.g. poor compliance), Autoimmune disorders, Severe chronic inflammatory diseases, Malignancy, Alcohol abuse, Existing or intended pregnancy, lactation and/or lack of adequate contraceptive protection, Patients being in any relationship or dependency with the sponsor and/or investigator, Treatment with betablockers (incl. local application) and/or other contraindicated drugs.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>